샘플 요청 목록

 카트 문의
시장보고서
상품코드
1807405

세계의 동물용 원료의약품 제조 시장 : 규모, 점유율 및 동향, 업계 분석(서비스 유형별, 합성 유형별, 동물 유형별 치료 카테고리별, 지역별), 예측(2025-2034년)

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Service Type, By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region - Market Forecast, 2025-2034
발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 125 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 동물용 원료의약품 제조 시장 규모는 2034년까지 170억 8,000만 달러에 달할 전망입니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

동물용 원료의약품(VAPI)은 동물 질병의 치료, 예방, 진단에 사용되는 의약품의 생물학적 활성 물질입니다. 의도한 치료 효과를 가져오는 핵심 성분입니다. 동물용 원료의약품(VAPI) 제조는 생물학적 활성 물질을 합성 또는 추출하는 복잡하고 고도로 규제된 공정입니다. 여기에는 화학 합성, 발효 또는 천연 공급원으로부터의 분리가 포함되며, 그 후 정체성, 효능, 순도 및 안전성을 보장하기 위해 광범위한 정제 및 엄격한 품질 관리가 수행됩니다.

동물용 원료의약품의 제조 공정은 FDA나 EMA 등 당국이 정한 엄격한 적정 제조 규범(GMP) 기준을 준수해야 합니다. 신진 대사 속도, 소화 시스템, 특정 질병 병원체를 포함한 동물 종 간의 생리적 차이도 원료의 설계, 합성 및 정제에 영향을 미칩니다.

동물용 원료의약품 제조 시장 : 분석 개요

서비스 유형별로는 동물용 의약품 대기업이 제조 공정의 관리 유지를 강력히 희망하고 있기 때문에 2024년의 수익 점유율은 자사 부문이 64.32%를 차지했습니다.

합성 유형별로는 화학 기반 API 부문이 2024년 수익 점유율의 72.34%를 차지했습니다. 화학 합성은 확장성, 비용 효율성, 일관성을 제공하며 가축과 반려동물 모두에서 일반적인 증상을 대상으로 하는 의약품의 제조에 선호되는 선택입니다.

동 물유형별로는 육류, 낙농, 닭고기 제품 수요 증가로 2024년 생산동물 부문이 수익 점유율의 61.32%를 차지했습니다.

치료 카테고리별로는 반려동물과 가축에서 박테리아와 바이러스성 질환의 위협이 뿌리 깊기 때문에 항감염제 부문이 2024년에 가장 큰 수익 점유율을 차지했습니다.

북미의 동물용 원료의약품 제조 시장은 2024년에 가장 큰 수익 점유율을 차지했습니다. 이것은 동반 동물의 사육률 증가로 인한 것입니다.

아시아태평양 산업은 향후 몇 년 동안 가장 빠른 속도로 성장할 것으로 예측됩니다. 이는 중류계급 인구 증가, 반려동물 소유율 증가, 동물 럭셔리 의학 지출 증가로 인한 것입니다.

세계 주요 기업은 Alivira Animal Health Limited, AMGIS Lifescience Ltd., Bimeda Inc., ChemPro Pharma Private Limited, Excel Industries Limited, FIS-Fabbrica Italiana Sintetici SpA, Grupo Indukern SL, Huvepharma AD, Huateng Pharma, Mena BV, SUANFARMA SA, Zoetis Inc. 등이 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 분석 방법

제4장 세계의 동물용 원료의약품 제조 시장 인사이트

  • 시장 현황
  • 동물용 원료의약품 제조 시장 역학
    • 성장 촉진요인과 기회
      • 동물 건강에 관한 지출 증가
      • 시설 확장에 대한 투자 증가
    • 억제요인과 과제
      • 엄격한 규제
  • PESTLE 분석
  • 동물용 원료의약품 제조 시장 동향
  • 밸류체인 분석

제5장 세계의 동물용 원료의약품 제조 시장 : 서비스 유형별

  • 주요 분석 결과
  • 소개
  • 사내 생산
  • 외주 생산

제6장 세계의 동물용 원료의약품 제조 시장 : 합성 유형별

  • 주요 분석 결과
  • 소개
  • 화학 기반 API
  • 생물학적 API
  • HPAPI

제7장 세계의 동물용 원료의약품 제조 시장 : 동물 유형별

  • 주요 분석 결과
  • 소개
  • 생산동물
  • 반려동물

제8장 세계의 동물용 원료의약품 제조 시장 : 치료 카테고리별

  • 주요 분석 결과
  • 소개
  • 항기생충약
  • 항감염증약
  • NSAID
  • 기타

제9장 세계의 동물용 원료의약품 제조 시장 : 지역별

  • 주요 분석 결과
  • 소개
    • 동물용 원료의약품 제조 시장 분석 : 지역별(2020-2034년)
  • 북미
    • 북미 : 서비스 유형별(2020-2034년)
    • 북미 : 합성 유형별(2020-2034년)
    • 북미 : 동물 유형별(2020-2034년)
    • 북미 : 치료 카테고리별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 서비스 유형별(2020-2034년)
    • 유럽 : 합성 유형별(2020-2034년)
    • 유럽 : 동물 유형별(2020-2034년)
    • 유럽 : 치료 카테고리별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양 : 서비스 유형별(2020-2034년)
    • 아시아태평양 : 합성 유형별(2020-2034년)
    • 아시아태평양 : 동물 유형별(2020-2034년)
    • 아시아태평양 : 치료 카테고리별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 서비스 유형별(2020-2034년)
    • 중동 및 아프리카 : 합성 유형별(2020-2034년)
    • 중동 및 아프리카 : 동물 유형별(2020-2034년)
    • 중동 및 아프리카 : 치료 카테고리별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 서비스 유형별(2020-2034년)
    • 라틴아메리카 : 합성 유형별(2020-2034년)
    • 라틴아메리카 : 동물 유형별(2020-2034년)
    • 라틴아메리카 : 치료 카테고리별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제10장 경쟁 구도

  • 사업 확대 및 기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴/협업/합의/공개

제11장 기업 프로파일

  • Alivira Animal Health Limited
  • AMGIS Lifescience Ltd.
  • Bimeda Inc.
  • Chempro Pharma Private Limited
  • Excel Industries Limited
  • FIS-Fabbrica Italiana Sintetici SpA
  • Grupo Indukern SL
  • Huateng Pharma
  • Huvepharma AD
  • Menadiona SL
  • NGL Fine-Chem Ltd.
  • Ofichem Group BV
  • SUANFARMA SA
  • Zoetis Inc.
JHS 25.09.22

The veterinary active pharmaceutical ingredients manufacturing market size is expected to reach USD 17.08 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Service Type (In-House and Contract Outsourcing), By Synthesis Type, By Animal Type, By Therapeutic Category, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary active pharmaceutical ingredients (VAPIs) are the biologically active substances in medicinal products used to treat, prevent, or diagnose diseases in animals. They are the core components responsible for the intended therapeutic effect. Veterinary active pharmaceutical ingredients (VAPIs) manufacturing is the complex, highly regulated process of synthesizing or extracting biologically active substances. This involves chemical synthesis, fermentation, or isolation from natural sources, followed by extensive purification and stringent quality control to ensure identity, potency, purity, and safety.

The manufacturing process of veterinary active pharmaceutical ingredients must adhere to rigorous good manufacturing practice (GMP) standards set by authorities like the FDA and EMA. The physiological differences between species, such as metabolic rates, digestive systems, and specific disease pathogens, also influence the design, synthesis, and purification of the API.

Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report Highlights

In terms of service type, the in-house segment accounted for 64.32% of revenue share in 2024 due to the strong preference of major veterinary pharmaceutical companies to maintain control over their production processes.

Based on synthesis type, the chemical-based API segment held 72.34% of the revenue share in 2024. Chemical synthesis provided scalability, cost efficiency, and consistency, making it the preferred choice for manufacturing drugs that target common conditions in both livestock and companion animals.

In terms of animal type, the production animals segment accounted for 61.32% of revenue share in 2024 due to rising demand for meat, dairy, and poultry products.

Based on therapeutic category, the anti-infectives segment held the largest revenue share in 2024 due to the persistent threat of bacterial and viral diseases in companion and farm animals.

North America veterinary active pharmaceutical ingredients manufacturing market accounted for the largest revenue share in 2024. This dominance is attributed to rising companion animal ownership rates.

The industry in the Asia Pacific is projected to grow at the fastest pace in the coming years, owing to a growing middle-class population, increasing pet ownership, and rising spending on premium veterinary care.

A few global key market players include Alivira Animal Health Limited; AMGIS Lifescience Ltd.; Bimeda Inc.; Chempro Pharma Private Limited; Excel Industries Limited; FIS - Fabbrica Italiana Sintetici S.p.A.; Grupo Indukern S.L.; Huvepharma AD; Huateng Pharma; Menadiona S.L.; NGL Fine-Chem Ltd.; Ofichem Group B.V.; SUANFARMA S.A.; and Zoetis Inc.

Polaris Market Research has segmented the market report on the basis of service type, synthesis type, animal type, therapeutic category, and region:

By Service Type Outlook (Revenue, USD Billion, 2020-2034)

In House

Contract Outsourcing

Contract Development

Preclinical Development

Clinical Development

Contract Manufacturing

By Synthesis Type Mode Outlook (Revenue, USD Billion, 2020-2034)

Chemical-based API

Biological API

HPAPI

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

Production Animals

Companion Animals

By Therapeutic Category Outlook (Revenue, USD Billion, 2020-2034)

Antiparasitics

Anti-infectives

NSAIDs

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Insights

  • 4.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Market Snapshot
  • 4.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Expenditure on Animal Health
      • 4.2.1.2. Increasing Investment in Facility Expansion
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Regulation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
  • 5.3. In House
    • 5.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by In House, by Region, 2020-2034 (USD Billion)
  • 5.4. Contract Outsourcing
    • 5.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Outsourcing, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Contract Development
      • 5.4.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Development, by Region, 2020-2034 (USD Billion)
      • 5.4.2.2. Preclinical Development
      • 5.4.2.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Preclinical Development, by Region, 2020-2034 (USD Billion)
      • 5.4.2.3. Clinical Development
      • 5.4.2.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Clinical Development, by Region, 2020-2034 (USD Billion)
    • 5.4.3. Contract Manufacturing
      • 5.4.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Contract Manufacturing, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
  • 6.3. Chemical-based API
    • 6.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Chemical-based API, by Region, 2020-2034 (USD Billion)
  • 6.4. Biological API
    • 6.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Biological API, by Region, 2020-2034 (USD Billion)
  • 6.5. HPAPI
    • 6.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by HPAPI, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
  • 7.3. Production Animals
    • 7.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Production Animals, by Region, 2020-2034 (USD Billion)
  • 7.4. Companion Animals
    • 7.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Companion Animals, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 8.3. Antiparasitics
    • 8.3.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Antiparasitics, by Region, 2020-2034 (USD Billion)
  • 8.4. Anti-infectives
    • 8.4.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Anti-infectives, by Region, 2020-2034 (USD Billion)
  • 8.5. NSAIDs
    • 8.5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by NSAIDs, by Region, 2020-2034 (USD Billion)
  • 8.6. Others
    • 8.6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - North America
    • 9.3.1. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.3.3. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.3.4. North America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.3.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - US
      • 9.3.5.1. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.3.5.2. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.3.5.3. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.5.4. US: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.3.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Canada
      • 9.3.6.1. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Europe
    • 9.4.1. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UK
      • 9.4.5.1. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - France
      • 9.4.6.1. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Germany
      • 9.4.7.1. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Italy
      • 9.4.8.1. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Spain
      • 9.4.9.1. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Netherlands
      • 9.4.10.1. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Russia
      • 9.4.11.1. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.4.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Asia Pacific
    • 9.5.1. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - China
      • 9.5.5.1. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - India
      • 9.5.6.1. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Malaysia
      • 9.5.7.1. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Japan
      • 9.5.8.1. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Indonesia
      • 9.5.9.1. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.10. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Korea
      • 9.5.10.1. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.11. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Australia
      • 9.5.11.1. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.5.12. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - UAE
      • 9.6.6.1. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Israel
      • 9.6.7.1. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - South Africa
      • 9.6.8.1. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.6.9. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
  • 9.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Latin America
    • 9.7.1. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Mexico
      • 9.7.5.1. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Brazil
      • 9.7.6.1. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Argentina
      • 9.7.7.1. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)
    • 9.7.8. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Service Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Synthesis Type, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Animal Type, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Therapeutic Category, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alivira Animal Health Limited
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AMGIS Lifescience Ltd.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bimeda Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Chempro Pharma Private Limited
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Excel Industries Limited
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. FIS - Fabbrica Italiana Sintetici S.p.A.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Grupo Indukern S.L.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Huateng Pharma
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Huvepharma AD
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Menadiona S.L.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. NGL Fine-Chem Ltd.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Ofichem Group B.V.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. SUANFARMA S.A
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Zoetis Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제